Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[11C]methoxyphenyl)pyridin-3-yl)methyl)cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors-Reference-Cited by-同舟云学术

Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[11C]methoxyphenyl)pyridin-3-yl)methyl)cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors

Published:2014-09 Issue:8 Volume:41 Page:670-680
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Christiaans Johannes A.M.,Klein Pieter J.,Metaxas Athanasios,Kooijman Esther J.M.,Schuit Robert C.,Leysen Josée E.,Lammertsma Adriaan A.,van Berckel Bart N.M.,Windhorst Albert D.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference31 articles.

1. NMDA receptor pathways as drug targets;Kemp;Nat Neurosci,2002

2. Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists;Beinat;Curr Med Chem,2010

3. Pharmacology of ionotropic glutamate receptors: A structural perspective;Stawski;Bioorg Med Chem,2010

4. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential;Mony;Br J Pharmacol,2009

5. Glutamate Receptor Ion Channels: Structure, Regulation, and Function;Traynelis;Pharmacol Rev,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamate’s Effects on the N-Methyl-D-Aspartate (NMDA) Receptor Ion Channel in Alzheimer’s Disease Brain: Challenges for PET Radiotracer Development for Imaging the NMDA Ion Channel;Molecules;2023-12-19

2. Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic System;CHIMIA;2020-12-23

3. A Review of Molecular Imaging of Glutamate Receptors;Molecules;2020-10-16

4. Development of PET and SPECT Radioligands for In Vivo Imaging of NMDA Receptors;PET and SPECT of Neurobiological Systems;2020-09-30

5. N-Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present);Expert Opinion on Therapeutic Patents;2020-09-14